Michels Foundation Fellowship, the Heed Foundation Fellowship, and the American Society of Retinal Specialists Honor Award.ĭr.
Jeffers Prize, Association of University Professors of Ophthalmology /Research to Prevent Blindness Resident and Fellow Research Award, Ronald G. Hahn has also been the recipient of numerous prestigious honors and awards for excellence in ophthalmology research, receiving the Dr. He has been the invited participant of American Academy of Ophthalmology Board of Trustees strategic retreat and selected participant of Heed Ophthalmic Foundation annual retreat.ĭr. He has remained active as a consultant and advisory board member for major surgical and therapeutic companies and serves on the editorial board of multiple ophthalmic journals, including as a serving member of the American Society of Retina Specialists – Research and Safety in Therapeutics Committee. He has also supervised and provided expert guidance for complex surgeries in the United States and around the world. He has lectured at numerous national and international meetings on topics including macular degeneration, diabetic retinopathy, retinal vascular disease, retinal detachment, macular hole, epiretinal membrane, ocular imaging, and advanced surgical techniques. Hahn has published more than 50 peer-reviewed articles and book chapters and served as principal investigator for multiple clinical trials. Hahn’s pioneering surgery published around the world. This groundbreaking surgery caught the attention of local, national, and international media, with stories about Dr. The surgery helps restore vision in people with the degenerative disease retinosa pigmentosa. This was the first robotic eye ever implanted in the Southeast, and only the seventh time it had been done in the entire United States. Hahn first implanted the Argus II-a retinal prosthesis system that is often called a bionic eye. This led him to found the Duke Center for Artificial and Regenerative Vision, where he served as director. Hahn developed an interest in next-generation treatments and cutting edge technologies.
#NEW JERSEY RETINA WAYNE NJ FULL#
Hahn remained at Duke University as an Assistant Professor of Ophthalmology at Duke’s medical school for nearly four years, where he gained experience in managing the full range of eye conditions, including the most complex of complications.Īs a surgeon at Duke University Eye Center, Dr.
Hahn then completed his ophthalmology residency at the Scheie Eye Institute at the University of Pennsylvania, followed by a two-year fellowship in vitreoretinal diseases and surgery at Duke University.Īfter he completed his fellowship, Dr. He was sponsored by the National Institute of Health for completion of his MD, along with a PhD degree in molecular pharmacology investigating novel treatment pathways for dry age-related macular degeneration. He then followed in the footsteps of his father and grandfather, who were both ophthalmologists, and completed his medical education at the University of Pennsylvania School of Medicine. He then graduated magna cum laude from Harvard University with a degree in Biochemical Sciences. Hahn attended Harvard University where he was awarded the Detur Prize for Academic Achievement of the Highest Distinction – awarded to top 5-10% of first- year students based on academic merit-the John Harvard Scholarship for academic excellence.
Paul Hahn, a New York City native and pioneering eye surgeon, returned to the northeast in 2016 to join the medical staff at Clara Maass Medical Center and the advanced eye care team at NJRetina.ĭr.
0 kommentar(er)
